Affordable Ceretone OTC Hearing Aids Now Available at Target Stores Nationwide
LOS ANGELES, June 30, 2025 /PRNewswire/ -- Ceretone, a pioneering force in affordable hearing technology, today announces the nationwide launch of its over-the-counter (OTC) hearing aids at Target stores and Target.com. The company has established itself as a leading OTC hearing aid brand in major retail channels, demonstrating strong consumer demand for accessible hearing aids. This collaboration brings five innovative...
Heaven Gifts Releases Latest Sustainability Report
This year's Sustainability Report details key milestones across five focuses in 2024 Continued dedication to compliance and self-regulation highlighted Product safety a priority in bringing all-around adult user experience Product lifecycle carbon footprint verification completed LONDON, June 30, 2025 /PRNewswire/ -- Heaven Gifts, a global vaping industry leader, releases its...
Noul Publishes Its Fifth Sustainability Report, Outlining a Vision for Growth and a Decade of Breakthroughs
"The next decade will focus on securing strong growth momentum by strengthening product competitiveness and profitability" First technology-special listed company to join the Corporate Value-Up Program… "We will grow by faithfully responding to stakeholder needs and expectations." YONGIN, South Korea, June 30, 2025 /PRNewswire/ -- Noul Co., Ltd. (CEO: David...
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline
Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: With the 100th participant enrolled in the XanaMIA trial, the timeline for the planned interim analysis is confirmed for January 2026 and the timeline for final results reconfirmed for late 2026 An independent Data Monitoring Committee will...
Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals
TOKYO, June 30, 2025 /PRNewswire/ -- Alpha Fusion, Inc. ("Alpha Fusion") and Curadh MTR Inc. ("Curadh") announced plans to enter a strategic partnership, including a Joint Venture to broadly advance the global development of Astatine-211 (At-211) based radiopharmaceuticals. The collaboration combines Alpha Fusion's leading role in At-211 drug discovery and early clinical work in Japan, with Curadh's global expertise in...
WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL
The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces viscosity by up to 90% while maintaining formulation stability and injectability SHANGHAI, June 30, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXiHigh™2.0, a high-throughput...
Japanese Body Therapy (JBT) Launches Singapore-Based Expansion Hub, Targets 100 Centres Across Asia
SINGAPORE, June 30, 2025 /PRNewswire/ -- MJG INTERNATIONAL PTE. LTD. has formally launched Japanese Body Therapy (JBT) in Singapore, positioning the city-state as its operational base for regional growth. JBT is a structured body therapy brand offering PM Balance Seitai—a traditional Japanese manual therapy focused on posture and structural alignment....
Smartee Unveils ‘Live Update’ to Slash Treatment Planning Time from Days to Seconds
SHANGHAI, June 30, 2025 /PRNewswire/ -- In an era where real-time treatment agility defines competitive orthodontic care, Smartee's Live Update has emerged as a game-changer for clear aligner workflows. Introduced in February 2025, this new AI-powered feature on the SmarteeCheck platform is now already fully operational worldwide, slashing treatment plan modification time from days to just 20 seconds. ...
Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care
NEW YORK, June 30, 2025 /PRNewswire/ -- For individuals managing respiratory conditions, every breath matters—and so does the freedom to move, explore, and live life on their own terms. At VARON, that belief is at the heart of everything we do. With our trusted line of portable oxygen concentrators, VARON continues to empower...
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS
NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS). A unique RNA splice variant of the human gene...
